Should Texas Plavix Lawsuit Prompt Fresh Risk Assessment From Bristol-Myers Squibb

Texas Attorney General Ken Paxton sued Bristol-Myers Squibb and Sanofi in November 2025, alleging failure to disclose that blood thinner Plavix has reduced efficacy in certain ethnic groups due to genetic factors. The lawsuit claims violations of state consumer protection laws, with millions of Texans improperly prescribed the medication, raising patient safety concerns and financial impact on taxpayer-funded healthcare programs.